Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #7372
Reference
MSAN(2021)23
Name
Catapres® (clonidine) 100microgram tablets
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
DRUG THERAPY
PHARMACEUTICAL SERVICES
SUPPLIES
Description
1. Very limited supplies of Catapres® (clonidine) 100microgram tablets are available until w/c 4th October 2021.
2. Clonidine 25 microgram tablets remain available and able to support a full increase in demand.
3. Clonidine 50 microgram /5ml oral solution sugar free remain available and able to support a full increase in demand.
4. The above preparations have different licensed indications (management of migraine or recurrent vascular headache and management of vasomotor conditions commonly associated with the menopause and characterised by flushing) to Catapres® 100 microgram tablets.
5. Unlicensed imports of clonidine 100 microgram tablets can be sourced. Lead times vary.
2. Clonidine 25 microgram tablets remain available and able to support a full increase in demand.
3. Clonidine 50 microgram /5ml oral solution sugar free remain available and able to support a full increase in demand.
4. The above preparations have different licensed indications (management of migraine or recurrent vascular headache and management of vasomotor conditions commonly associated with the menopause and characterised by flushing) to Catapres® 100 microgram tablets.
5. Unlicensed imports of clonidine 100 microgram tablets can be sourced. Lead times vary.
Contact Name
Contact Email
Contact Address
Created
2021-08-03 00:00:00
Click to go back to homepage